» Articles » PMID: 12686539

Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis: Distribution of Homo- and Heterodimers Depends on Relative HER2 Levels

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 11
PMID 12686539
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Endocytic trafficking plays an important role in the regulation of the epidermal growth factor receptor (EGFR) family. Many cell types express multiple EGFR family members (including EGFR, HER2, HER3, and/or HER4) that interact to form an array of homo- and heterodimers. Differential trafficking of these receptors should strongly affect signaling through this system by changing substrate access and heterodimerization efficiency. Because of the complexity of these dynamic processes, we used a quantitative and computational model to understand their integrated operation. Parameters characterizing EGFR and HER2 interactions were determined using experimental data obtained from mammary epithelial cells constructed to express different levels of HER2, enabling us to estimate receptor-specific internalization rate constants and dimer uncoupling rate constants. Significant novel results obtained from this work are as follows: first, that EGFR homodimerization and EGFR/HER2 heterodimerization occur with comparable affinities; second, that EGFR/HER2 heterodimers traffic as single entities. Furthermore, model predictions of the relationship of HER2 expression levels to consequent distribution of EGFR homodimers and EGFR/HER2 heterodimers suggest that the levels of HER2 found on normal cells are barely at the threshold necessary to drive efficient heterodimerization. Thus, altering HER2 concentrations, either overall or local, could provide an effective mechanism for regulating EGFR/HER2 heterodimerization and may explain why HER2 overexpression found in some cancers has such a profound effect on cell physiology.

Citing Articles

Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.

Ujlaky-Nagy L, Szollosi J, Vereb G Int J Mol Sci. 2024; 25(11).

PMID: 38892166 PMC: 11173106. DOI: 10.3390/ijms25115978.


The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.

ONeill C, Sun K, Sundararaman S, Chang J, Glynn S Front Physiol. 2024; 15:1358850.

PMID: 38601214 PMC: 11004480. DOI: 10.3389/fphys.2024.1358850.


Molecular characteristics of gastric cancer with amplification.

Cao D, Xu H, Li L, Ju Z, Zhai B Heliyon. 2023; 9(8):e18654.

PMID: 37554835 PMC: 10405018. DOI: 10.1016/j.heliyon.2023.e18654.


Synthesis of Site-Specific Antibody-[60]Fullerene-Oligonucleotide Conjugates for Cellular Targeting.

Aarela A, Rasanen K, Holm P, Salo H, Virta P ACS Appl Bio Mater. 2023; 6(8):3189-3198.

PMID: 37432881 PMC: 10445261. DOI: 10.1021/acsabm.3c00318.


ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.

Morato A, Accornero P, Hovey R J Mammary Gland Biol Neoplasia. 2023; 28(1):10.

PMID: 37219601 PMC: 10205859. DOI: 10.1007/s10911-023-09538-w.